
Sobi offers the opportunity to work at an international pharmaceutical company focused on specialty pharmaceuticals meeting the high medical needs of rare disease patients and providing treatment and services to them. Our employees come from a variety of backgrounds within research, healthcare, industry and the academic sphere.
The Specialty care Launch Lead, International is responsible for launch readiness and cross-regional pre-launch activities across the International region, with a clear focus on accelerating appropriate patient identification and uptake in alignment with Sobi’s mission to improve the lives of people living with FSC/sTGH. You will drive cross-functional execution across Commercial, Medical and Market Access, as well as external partners, to enable timely and compliant adoption of diagnostic pathways and pre-launch engagement. You will establish scalable frameworks and performance metrics that translate scientific insights into actionable plans—while upholding high ethical standards and patient-centricity.
Key responsibilities
All your information will be kept confidential according to EEO guidelines.

Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases.
We are dedicated to capturing the scientific opportunities of our time. With our early roots in Sweden, we started as pioneers in haemophilia. Today we are an innovative leader within rare diseases with a global reach. Together we are bringing brilliant ideas to life.
Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK 26 billion. Sobi’s share (STO:SOBI) is listed on Nasdaq Stockholm. More about Sobi at sobi.com and LinkedIn.